KIT and ovarian carcinoma: These biological behaviours of CDC50A+ ovarian cancer cells were consistent with those of ovarian cancer cells with positive expression of several classic stem cell surface biomarkers, such as CD44 [31], CD117 [32], CD24 [33] and CD133 [34].